Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Rhabdoid Tumor × Panobinostat × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 29 Recurrence 13 Leukemia, Myeloid, Acute 13 Hodgkin Disease 12 Neoplasms 10 Lymphoma 9 Myelodysplastic Syndromes 8 Lymphoma, Non-Hodgkin 8 Lymphoma, Large B-Cell, Diffuse 8 Breast Neoplasms 8 Precursor Cell Lymphoblastic Leukemia-Lymphoma 7 Leukemia 6 Carcinoma, Non-Small-Cell Lung 6 Prostatic Neoplasms 5 Neoplasms, Plasma Cell 5 Lymphoma, T-Cell, Cutaneous 5 Lymphoma, Mantle-Cell 5 Leukemia, Lymphocytic, Chronic, B-Cell 5 Waldenstrom Macroglobulinemia 4 Sezary Syndrome 4 Neoplasm Metastasis 4 Mycosis Fungoides 4 Lymphoma, Large-Cell, Anaplastic 4 Lymphoma, Extranodal NK-T-Cell 4 Immunoblastic Lymphadenopathy 4 Glioma 4 Advanced Solid Tumors 4 Primary Myelofibrosis 3 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3 Lymphoma, Follicular 3

Interventions

Cyclophosphamide 14 Etoposide 10 Magnetic Resonance Spectroscopy 8 Carboplatin 8 X-Rays 7 Phantoms, Imaging 7 Granulocyte Colony-Stimulating Factor 7 tazemetostat 6 etoposide phosphate 6 Thiotepa 6 Temozolomide 6 Specimen Handling 6 Filgrastim 6 fludarabine 5 Vincristine 5 Topotecan 5 Stem Cell Transplantation 5 Radiotherapy 5 Nuclear Medicine Department, Hospital 5 Methotrexate 5 Cisplatin 5 Melphalan 4 Biopsy 4 palbociclib 3 fludarabine phosphate 3 Sirolimus 3 Peripheral Blood Stem Cell Transplantation 3 Mesna 3 Ifosfamide 3 Busulfan 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04897880 2025-02-24

NORTH

Australian & New Zealand Children's Haematology/Oncology Group

Phase 2 Terminated

Brain Neoplasms, Rhabdoid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡